Eli Lilly Co Drug Patent Portfolio

Eli Lilly Co's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Eli Lilly Co News

The Competition Intensifies: Novo Looks to Wegovy to Regain Dominance Over Eli Lilly

14 Mar, 2026

Wegovy Encounters Challenges as Novo Nordisk Shifts Strategy and Teams Up with Hims & Hers

14 Mar, 2026

Mounjaro manufacturer cautions about risks associated with counterfeit weight-loss medications - DailyMail.com

13 Mar, 2026

Novo Nordisk Becomes a Defensive Investment Option for DACH Investors - Born2Invest

13 Mar, 2026

See More